title: Types A and B Niemann-Pick Disease.
abstract: Two distinct metabolic abnormalities are included under the eponym Niemann-Pick disease (NPD). The first is due to the deficient activity of the enzyme acid sphingomyelinase (ASM). Patients with ASM deficiency are classified as having types A and B Niemann-Pick disease (NPD). Type A NPD patients exhibit hepatosplenomegaly, frequent pulmonary infections, and profound central nervous system involvement in infancy. They rarely survive beyond two years of age. Type B patients also have hepatosplenomegaly and progressive alterations of their lungs, but there are usually no central nervous system signs. The age of onset and rate of disease progression varies greatly among type B patients, and they frequently live into adulthood. Recently, patients with phenotypes intermediate between types A and B NPD also have been identified. These individuals represent the expected continuum caused by inheriting different mutations in the ASM gene (SMPD1). Patients in the second category are designated as having type C NPD. Impaired intracellular trafficking of cholesterol causes type C NPD, and two distinct gene defects have been found. In this chapter only types A and B NPD will be discussed.
authors.forename: Edward H
authors.initials: EH
authors.lastname: Schuchman
authors.forename: Melissa P
authors.initials: MP
authors.lastname: Wasserstein
mesh_terms: D017668:Age of Onset; D000818:Animals; D016026:Bone Marrow Transplantation; D002493:Central Nervous System Diseases / Q000503:physiopathology; D004195:Disease Models, Animal; D018450:Disease Progression; D056947:Enzyme Replacement Therapy; D015316:Genetic Therapy; D006529:Hepatomegaly; D006801:Humans; D008171:Lung Diseases / Q000503:physiopathology; D009154:Mutation; D052536:Niemann-Pick Disease, Type A / Q000235:genetics / Q000503:physiopathology / Q000628:therapy*; D052537:Niemann-Pick Disease, Type B / Q000235:genetics / Q000503:physiopathology / Q000628:therapy*; D010641:Phenotype; D013108:Sphingomyelin Phosphodiesterase / Q000235:genetics / Q000627:therapeutic use*; D013163:Splenomegaly
chemical_list: C543066:SMPD1 protein, human; D013108:Sphingomyelin Phosphodiesterase